A citation-based method for searching scientific literature


List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
33

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo. Adv Ther 2017
267
19

Nonobese Fatty Liver Disease.
Donghee Kim, W Ray Kim. Clin Gastroenterol Hepatol 2017
200
14

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
14

Nonalcoholic fatty liver disease in lean individuals in the United States.
Zobair M Younossi, Maria Stepanova, Francesco Negro, Shareh Hallaji, Youssef Younossi, Brian Lam, Manirath Srishord. Medicine (Baltimore) 2012
334
14

More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.
Paulina Chinchilla-López, Oscar Ramírez-Pérez, Vania Cruz-Ramón, Samuel Canizales-Quinteros, Aarón Domínguez-López, Guadalupe Ponciano-Rodríguez, Fausto Sánchez-Muñoz, Nahum Méndez-Sánchez. Ann Hepatol 2018
20
15


Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J Sanyal. Hepatology 2018
905
14

Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.
S M B Duarte, J T Stefano, L Miele, F R Ponziani, M Souza-Basqueira, L S R R Okada, F G de Barros Costa, K Toda, D F C Mazo, E C Sabino,[...]. Nutr Metab Cardiovasc Dis 2018
61
14

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
14

Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Nicole E Rich, Stefany Oji, Arjmand R Mufti, Jeffrey D Browning, Neehar D Parikh, Mobolaji Odewole, Helen Mayo, Amit G Singal. Clin Gastroenterol Hepatol 2018
177
14

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Zobair Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jiangao Fan,[...]. Hepatology 2019
724
14

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Elena Buzzetti, Massimo Pinzani, Emmanuel A Tsochatzis. Metabolism 2016
9

Hypogonadism and non-alcoholic fatty liver disease.
Gesthimani Mintziori, Pavlos Poulakos, Christos Tsametis, Dimitrios G Goulis. Minerva Endocrinol 2017
47
9

Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency.
T Ichikawa, K Hamasaki, H Ishikawa, E Ejima, K Eguchi, K Nakao. Gut 2003
83
9


Estrogens and female liver health.
Karen L Chen, Zeynep Madak-Erdogan. Steroids 2018
30
9

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Arun J Sanyal, Naga Chalasani, Kris V Kowdley, Arthur McCullough, Anna Mae Diehl, Nathan M Bass, Brent A Neuschwander-Tetri, Joel E Lavine, James Tonascia, Aynur Unalp,[...]. N Engl J Med 2010
9

Non-alcoholic Fatty Liver Disease: A Clinical Update.
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran. J Clin Transl Hepatol 2017
84
9

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, Len A Pennacchio, Eric Boerwinkle, Jonathan C Cohen, Helen H Hobbs. Nat Genet 2008
9

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
Hae Jin Kim, Hyeong Jin Kim, Kwang Eun Lee, Dae Jung Kim, Soo Kyung Kim, Chul Woo Ahn, Sung-Kil Lim, Kyung Rae Kim, Hyun Chul Lee, Kap Bum Huh,[...]. Arch Intern Med 2004
325
9

Non-alcoholic fatty liver disease: An expanded review.
Mark Benedict, Xuchen Zhang. World J Hepatol 2017
356
9

A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.
Zhonge Chen, Rong Yu, Ying Xiong, Fangteng Du, Shuishan Zhu. Lipids Health Dis 2017
139
9

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
Jeremy Lok Wei, Jonathan Chung-Fai Leung, Thomson Chi-Wang Loong, Grace Lai-Hung Wong, David Ka-Wai Yeung, Ruth Suk-Mei Chan, Henry Lik-Yuen Chan, Angel Mei-Ling Chim, Jean Woo, Winnie Chiu-Wing Chu,[...]. Am J Gastroenterol 2015
190
9

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.
Kerry L Donnelly, Coleman I Smith, Sarah J Schwarzenberg, Jose Jessurun, Mark D Boldt, Elizabeth J Parks. J Clin Invest 2005
9

Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity.
Leon A Adams, Julie A Marsh, Oyekoya T Ayonrinde, John K Olynyk, Wei Q Ang, Lawrence J Beilin, Trevor Mori, Lyle J Palmer, Wendy W Oddy, Steven J Lye,[...]. J Gastroenterol Hepatol 2012
28
9

Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Ryusaku Matsumoto, Hidenori Fukuoka, Genzo Iguchi, Hitoshi Nishizawa, Hironori Bando, Kentaro Suda, Michiko Takahashi, Yutaka Takahashi. Growth Horm IGF Res 2014
36
9

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
9

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Sayaka Chishima, Tomomi Kogiso, Noriko Matsushita, Etsuko Hashimoto, Katsutoshi Tokushige. Intern Med 2017
23
9

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
Julia Kozlitina, Eriks Smagris, Stefan Stender, Børge G Nordestgaard, Heather H Zhou, Anne Tybjærg-Hansen, Thomas F Vogt, Helen H Hobbs, Jonathan C Cohen. Nat Genet 2014
695
9


Nonalcoholic fatty liver disease in women.
Ayako Suzuki, Manal F Abdelmalek. Womens Health (Lond) 2009
93
9



Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
Jessica L Mellinger, Karol M Pencina, Joseph M Massaro, Udo Hoffmann, Sudha Seshadri, Caroline S Fox, Christopher J O'Donnell, Elizabeth K Speliotes. J Hepatol 2015
123
9

Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment.
Jason R Clapper, Michelle D Hendricks, Guibao Gu, Carrie Wittmer, Carrie S Dolman, John Herich, Jennifer Athanacio, Christiane Villescaz, Soumitra S Ghosh, Joseph S Heilig,[...]. Am J Physiol Gastrointest Liver Physiol 2013
163
9

Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.
Kristina R Chacko, John Reinus. Clin Liver Dis 2016
34
9

Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population.
Shamsul Mohd Zain, Zahurin Mohamed, Sanjiv Mahadeva, Sanjay Rampal, Roma Choudhury Basu, Phaik-Leng Cheah, Agus Salim, Rosmawati Mohamed. PLoS One 2013
28
9


Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Cathrin Sellmann, Cheng Jun Jin, Anna Janina Engstler, Jean-Pascal De Bandt, Ina Bergheim. Eur J Nutr 2017
21
9


Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
Cathrin Sellmann, Christian Degen, Cheng Jun Jin, Anika Nier, Anna Janina Engstler, Dana Hasan Alkhatib, Jean-Pascal De Bandt, Ina Bergheim. Amino Acids 2017
28
9

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Astrid Spruss, Giridhar Kanuri, Carolin Stahl, Stephan C Bischoff, Ina Bergheim. Lab Invest 2012
112
9

A regional vision of physical activity, sedentary behaviour and physical education in adolescents from Latin America and the Caribbean: results from 26 countries.
Nicolas Aguilar-Farias, Pia Martino-Fuentealba, Jaime Carcamo-Oyarzun, Andrea Cortinez-O'Ryan, Carlos Cristi-Montero, Astrid Von Oetinger, Kabir P Sadarangani. Int J Epidemiol 2018
50
9


Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage.
Eric R Kallwitz, Martha L Daviglus, Matthew A Allison, Kristen T Emory, Lihui Zhao, Mark H Kuniholm, Jinsong Chen, Natalia Gouskova, Amber Pirzada, Gregory A Talavera,[...]. Clin Gastroenterol Hepatol 2015
70
9


The prevalence of nonalcoholic fatty liver disease in the Americas.
Jorge A López-Velázquez, Karen V Silva-Vidal, Guadalupe Ponciano-Rodríguez, Norberto C Chávez-Tapia, Marco Arrese, Misael Uribe, Nahum Méndez-Sánchez. Ann Hepatol 2014
74
9

Nonalcoholic Fatty Liver Disease in Latinos.
Sammy Saab, Vignan Manne, Jose Nieto, Jeffrey B Schwimmer, Naga P Chalasani. Clin Gastroenterol Hepatol 2016
60
9

The Genetic Diversity of the Americas.
Kaustubh Adhikari, Juan Camilo Chacón-Duque, Javier Mendoza-Revilla, Macarena Fuentes-Guajardo, Andrés Ruiz-Linares. Annu Rev Genomics Hum Genet 2017
46
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.